Showing 3391-3400 of 4165 results for "".
- Eyenuk Announces FDA Clearance for EyeArt Autonomous AI System for Diabetic Retinopathy Screeninghttps://modernod.com/news/eyenuk-announces-fda-clearance-for-eyeart-autonomous-ai-system-for-diabetic-retinopathy-screening/2478123/Eyenuk announced it has received 510(k) clearance by the FDA to market its EyeArt autonomous AI System for diabetic retinopathy. EyeArt is indicated for use by health care providers to automatically detect more than mild diabetic retinopathy (mtmDR) and vision-threatening diabetic retinopa
- IAPB: Rethinking Global Health Means Including Eye-Healthhttps://modernod.com/news/iapb-rethinking-global-health-means-including-eye-health/2478120/Countries have agreed today to adopt a new resolution on vision in an effort to reach the 1 billion people worldwide who do not have access to vital eye care services, according to the International Agency for the Prevention of Blindness (IAPB). The resolution cements the World Health Orga
- Maculopathy Tied to Pentosan Polysulfate Sodium May Worsen After Drug Cessationhttps://modernod.com/news/maculopathy-tied-to-pentosan-polysulfate-sodium-may-worsen-after-drug-cessation/2478071/Pentosan polysulfate sodium (PPS)-associated maculopathy may continue for at least 10 years after drug cessation and in some cases may pose a threat to central vision, according to a case report, Reuters reported. The condition 
- GenSight Biologics Reports Final REALITY Study Confirms Poor Spontaneous Recovery for LHON Patients with ND4 mutationhttps://modernod.com/news/gensight-biologics-reports-final-reality-study-confirms-poor-spontaneous-recovery-for-lhon-patients-with-nd4-mutation/2478050/GenSight Biologics reported results from the final analysis of the REALITY natural history study, which reaffirm the poor prognosis for the vast majority of Leber Hereditary Optic Neuropathy (LHON) patients with vision loss due to a mutated ND4mitochondrial gene. “The REALITY findings bols
- CooperVision Encourages Free Registration for Focus on Eye Health National Summithttps://modernod.com/news/coopervision-encourages-free-registration-for-focus-on-eye-health-national-summit/2477992/CooperVision is encouraging the optometry, ophthalmology, vision science and public health communities to participate in the 9th annual “Focus on Eye Health National Summit,” presented by Prevent Blindness on Wednesday, July 15. The summit’s online format and no-cost
- Ocutrx Says It Will Deliver World’s First 5G AR/XR Medical Specific Platform in 2021https://modernod.com/news/ocutrx-says-it-will-deliver-worlds-first-5g-ar-xr-medical-specific-platform-in-2021/2477980/Ocutrx Vision Technologies announced plans to deliver the first AR headsets specific for medical applications providing connectivity from AT&T and using 5G products from Qualcomm Technologies. Ocutrx is building its AR/XR medical device, the Oculenz headset, for patient use; and a seco
- Two ARVO Papers Provide New Insights for Contact Lens-Based Myopia Management with Childrenhttps://modernod.com/news/two-arvo-papers-provide-new-insights-for-contact-lens-based-myopia-management-with-children/2477900/Two scientific papers being presented as part of the ARVO (Association for Research in Vision and Ophthalmology) 2020 virtual conference proceedings provide eye care professionals (ECPs) with new insights to aid contact lens-based myopia management with children. ReCSS Study Ex
- Coopervision Global Charity Releases its Annual Impact Report Highlighting Achievementshttps://modernod.com/news/coopervision-global-charity-releases-its-annual-impact-report-highlighting-achievements/2479515/As pediatric myopia increases globally in prevalence and severity, CooperVision remains committed to supporting programs such as “Our Children’s Vision” implemented by the Brien Holden Foundation that prioritize children’s eye health. Over the last 3 years, CooperVision has donated a
- ProQR Announces Virtual Presentation of Phase 1/2 Sepofarsen Data Through ARVOhttps://modernod.com/news/proqr-announces-virtual-presentation-of-phase-1-2-sepofarsen-data-through-arvo/2479525/ProQR Therapeutics announced a virtual presentation of data from the company’s phase 1/2 trial of sepofarsen. The data will be shared via a video presentation through the Association for Research in Vision and Ophthalmology (ARVO). It is the first time this data, previously announced in a
- Gil Kliman, MD, and Tom Frinzi Appointed to STAAR Surgical Board of Directorshttps://modernod.com/news/gil-kliman-md-and-tom-frinzi-appointed-to-staar-surgical-board-of-directors/2477846/Staar Surgical announced the appointment of Gilbert H. Kliman, MD, Managing Partner, InterWest Partners, and Thomas G. Frinzi, former Worldwide President, Surgical, Johnson & Johnson Vision, to its board of directors, effective June 1, 2020. The appointment of Dr. Kliman and Mr. Frinzi brings